These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 28608737)
1. Preoperative Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737 [TBL] [Abstract][Full Text] [Related]
2. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656 [TBL] [Abstract][Full Text] [Related]
3. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma. Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372 [TBL] [Abstract][Full Text] [Related]
4. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339 [TBL] [Abstract][Full Text] [Related]
5. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
6. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822 [TBL] [Abstract][Full Text] [Related]
8. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603 [TBL] [Abstract][Full Text] [Related]
9. Relative value of ultrasound, computed tomography and positron emission tomography imaging in the clinically node-negative neck in oral cancer. Chaukar D; Dandekar M; Kane S; Arya S; Purandare N; Rangarajan V; Deshmukh A; Pai P; Chaturvedi P; D'Cruz A Asia Pac J Clin Oncol; 2016 Jun; 12(2):e332-8. PubMed ID: 25131685 [TBL] [Abstract][Full Text] [Related]
10. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help? Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma. Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915 [TBL] [Abstract][Full Text] [Related]
12. Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma. Hirshoren N; Olayos E; Herschtal A; Ravi Kumar AS; Gyorki DE Otolaryngol Head Neck Surg; 2018 Jan; 158(1):122-126. PubMed ID: 28925330 [TBL] [Abstract][Full Text] [Related]
13. [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT. Suenaga Y; Kitajima K; Kanda T; Otsuki N; Nibu K; Sasaki R; Itoh T; Sugimura K Jpn J Radiol; 2016 Mar; 34(3):203-10. PubMed ID: 26670594 [TBL] [Abstract][Full Text] [Related]
14. Utility of SUV Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180 [TBL] [Abstract][Full Text] [Related]
15. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Jeong HS; Baek CH; Son YI; Ki Chung M; Kyung Lee D; Young Choi J; Kim BT; Kim HJ Head Neck; 2007 Mar; 29(3):203-10. PubMed ID: 17111430 [TBL] [Abstract][Full Text] [Related]
16. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma. Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of diffusion-weighted imaging and Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267 [TBL] [Abstract][Full Text] [Related]
18. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066 [TBL] [Abstract][Full Text] [Related]
19. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma. Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899 [TBL] [Abstract][Full Text] [Related]
20. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas. van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]